Your browser doesn't support javascript.
loading
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).
Fangusaro, Jason; Gururangan, Sridharan; Poussaint, Tina Young; McLendon, Roger E; Onar-Thomas, Arzu; Warren, Katherine E; Wu, Shengjie; Packer, Roger J; Banerjee, Anu; Gilbertson, Richard J; Jakacki, Regina; Gajjar, Amar; Goldman, Stewart; Pollack, Ian F; Friedman, Henry S; Boyett, James M; Kun, Larry E; Fouladi, Maryam.
Affiliation
  • Fangusaro J; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Cancer ; 119(23): 4180-7, 2013 Dec 01.
Article in En | MEDLINE | ID: mdl-24104527
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Camptothecin / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized Type of study: Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans / Infant Language: En Year: 2013 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Camptothecin / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized Type of study: Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans / Infant Language: En Year: 2013 Type: Article